As clinical trials become more complex, data sources multiply, and real-world evidence (RWE) gains prominence, the role of the statistician is evolving into clinical data scientists — hybrid professionals who combine technical expertise with strategic leadership to drive advancements in drug development.

Join us for an insightful webinar on how statisticians are leading innovation in today’s rapidly evolving clinical landscape. This webinar will explore how traditional randomized controlled trials (RCTs) are being reimagined through modern statistical methods, leveraging advanced data, infrastructure, clinical technology, and quantitative techniques to improve speed and reduce costs.

Key Topics

• The reimagined RCT: Explore how data, infrastructure, clinical technology, and emerging quantitative methods are converging to modernize clinical trials.
• The evolving role of the clinical data scientist: Understand how statisticians are transitioning from technical data analysts to strategic decision-makers, data translators, and leaders.
• Essential skills for success: Identify the critical skills needed to thrive in this evolving landscape, including expertise in statistics, data science, epidemiology, communication, and leadership.
• Leveraging real-world data (RWD): Learn how RWD is being integrated into clinical trials to inform trial design, expand sample sizes, and provide insights into drug performance in broader settings.
• Harnessing emerging quantitative methods: Discover how Bayesian methods, causal inference techniques, adaptive designs, and machine learning are being used to enhance clinical trials and decision-making.
• The impact of AI and machine learning: Examine how predictive algorithms, data-driven methods, and robust statistical frameworks are transforming personalized therapies and accelerating processes.
• Technical stewardship and ethical considerations: Recognize the need for technical expertise in navigating complex AI and statistical models, assessing data models’ strengths and limitations, and addressing ethical implications.
• Organizational adaptation: Discuss how organizations are breaking down functional silos and empowering clinical data science teams with decision-making roles.

Speakers

• Alexander Schacht, The Effective Statistician Podcast
• Yannis Jemiai, Chief Scientific Officer at Cytel
• Benjamin Piske, Global Head of Biostatistics at Cytel
• Flaminia Chiesa, Director Biostatistics at Cytel